Menu Back toCMIC Holdings Innovation Theater: Make the Impossible Possible - An Innovative Partnership for Market Entry in Japan

DIA 2021 Global Annual Meeting

CMIC Holdings Innovation Theater: Make the Impossible Possible - An Innovative Partnership for Market Entry in Japan

Session Chair(s)

CMIC HOLDINGS Co., Ltd.

CMIC HOLDINGS Co., Ltd.

  • CMIC Co., Ltd., Japan
CMIC, the leading CRO in Japan, and MEDIPAL, the leading pharma wholesaler joined forces to create OrphanPacific with a mission: accelerate the introduction of innovative medicines to treat rare diseases in Japan. Inspired by the experience of outsourcing, OrphanPacific introduced IPM, Innovative Pharma Model, assisting biotech firms without local operations to introduce their asset in Japan. The partnership with BioCryst provides an exceptional business case demonstrating the value of IPM.

Speaker(s)

Philippe Auvaro

Philippe Auvaro

  • OrphanPacific, Inc., President, Representative Director
  • CMIC HOLDINGS Co., Ltd./Orphan Pacific Inc, Japan
Megan Sniecinski, MBA

Megan Sniecinski, MBA

  • Chief Business Officer
  • BioCryst Pharmaceuticals, Inc., United States